Streetbeat News

Earnings

APYX

Apyx Medical's stock is trading lower due to the company providing weaker than expected financial guidance for the fiscal year 2024.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:56 am

LU

Lufax Holdings' shares are experiencing an uptick following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:55 am

CURI

Curiosity Stream's shares saw an increase following the announcement of mixed financial results for Q4. The company's performance in the last quarter has sparked investor interest, leading to a rise in its stock price.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:54 am

CMC

Commercial Metals Company (CMC) shares are experiencing an uptick due to the company reporting second-quarter earnings per share (EPS) and sales figures that surpassed analysts' expectations.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:50 am

CNTX

Context Therapeutics reported a fiscal year 2023 earnings per share (EPS) loss of $(1.50), compared to a loss of $(0.93) in the previous year. The company also reported a cash balance of $14.4 million.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:49 am

MU

STX

Seagate shares are trading higher, influenced by Micron's positive earnings report and strong future guidance. Micron's performance has positively impacted Seagate's stock.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:49 am

MU

WDC

Western Digital shares are trading higher, influenced by Micron's positive earnings report and strong future guidance.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:48 am

PZZA

Papa John's International is progressing with its Back to Better 2.0 growth strategy, aiming for a 2024 Adjusted Operating Income of $153M-$163M. The strategy includes marketing investments, new franchisee incentives, and international brand transformation. The company expects over 20% increase in North America net unit growth and 100-140 new international restaurants.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:46 am

PYXS

Pyxis Oncology (NASDAQ:PYXS) reported a FY EPS of $(1.85), surpassing the $(1.95) estimate, marking a 49.32% improvement from last year's $(3.65) per share loss. With $120.8M in cash and an additional $10.8M and $50M expected from an ATM offering and private placement, the company anticipates a cash runway into the second half of 2026.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:41 am

DBI

Designer Brands Inc. (DBI) shares dropped following the announcement of its Q4 financial results, revealing a 7.3% decrease in total comparable sales.

Portfolio Pulse from Benzinga Newsdesk

March 21, 2024 | 11:41 am